Announcements

2020
November 2020 Notice of General Meeting
November 2020 Notice of Annual General Meeting
November 2020 BPH Annual Report 2020
2018
February 2018 Summary Judgement Application dismissed
January 2018Corporate Governance Statement
2017
November 2017 Appendix 3B
November 2017 Non-Renounceable Issue
November 2017 Appointment of Corporate Development Director to Cortical
November 2017 Updated Capital Structure
November 2017 European marketing appointment for BPH investee Cortical
November 2017 Non-Renounceable Issue
October 2017Annual Report to shareholders
October 2017Appendix 4C – quarterly
October 2017Notice of Annual General Meeting/Proxy Form
October 2017Final Director’s Interest Notice
October 2017Initial Director’s Interest Notice
October 2017European trial for BPH investee Cortical BAR Monitor
October 2017Director Appointment/Resignation
October 2017MMR: Grandbridge Ltd – Notices
October 2017CHANGES TO PRELIMINARY FINANCIAL REPORT APPENDIX 4E
October 2017BPH MMR ASX Notice of Demand
October 2017BPH MEC Resources Ltd Dispute update
October 2017Appendix 4G BPH
October 2017Full Year Statutory Accounts
September 2017MEC Resources Ltd Dispute
September 2017MMR: Update on Discussions with BPH Energy Ltd
September 2017Preliminary Final Report
July 2017Appendix 4C – quarterly
July 2017WITHDRAWAL OF STATUTORY DEMAND & UPDATE DISPUTE WITH MMR
July 2017WITHDRAWAL OF STATUTORY DEMAND & UPDATE ON DISPUTE WITH MMR
July 2017MMR: Update on Dispute with BPH and GBA
July 2017MMR: BPH Energy Ltd – Statutory Demand
July 2017Statutory Demand Debt Offset
July 2017Tony Huston Appendix 3X
July 2017Appendix 3Z Bruce Whan
June 2017Director Appointment/Resignation
June 2017Final Director’s Interest Notice
June 2017Director Appointment/Resignation
June 2017Appendix 3B
April 2017Appendix 4C – quarterly
April 2017Results of General Meeting -Amendment
April 2017Results of Meeting
April 2017General meeting- non receipt of consents to act as Directors
April 2017Statutory Demand
April 2017Appendix 3B
April 2017Statutory Demand
April 2017Non-Renounceable Issue
March 2017Appendix 3B
March 2017Non-Renounceable Issue
March 2017Relodgement cover letter meeting-Change of address
March 2017Relodgement of cover letter to shareholders
March 2017Change in substantial holding
March 2017BPH Cover letter Notice of Meeting to shareholders
March 2017Change of Director’s Interest Notice
March 2017Change of Director’s Interest Notice
March 2017Change of Director’s Interest Notice
March 2017Appendix 3B
March 2017Completion of Rights Issue
February 2017European Patent Granted
February 2017Notices received under S 203D & 249D of Corps Act
February 2017Half Yearly Report and Accounts
February 2017BPH Rights issue extension
February 2017Update Appendix 4C
February 2017Update Notice received under S249D Corporations Act
February 2017Correction -Rights Issue Closing Date
February 2017RIGHTS ISSUE CLOSING DATE EXTENDED
February 2017Appendix 4C – quarterly
February 2017Non-Renounceable Issue
February 2017Notice received under Sections 203d and 249d
January 2017Non-Renounceable Issue
January 2017Notice received under Sections 203d and 249d
January 2017Response to ASX Appendix 3Y Query
January 2017Non-Renounceable Issue
January 2017Appendix 3B
January 2017Non-Renounceable Issue
2016
December 2016Non-Renounceable Issue
December 2016Change of Director’s Interest Notice
November 2016Resignation of Company Secretary
November 2016Results of Meeting
November 2016Share Placement – Appendix 3B
November 2016Cortical Wins Advanced Manufacturing Category in ATC Awards
October 2016Response to ASX Price & Volume Query
October 2016Appendix 4C – quarterly
October 2016Notice of Annual General Meeting/Proxy Form
October 2016Cortical Chosen as Finalist in Aust. Technology Competition
October 2016Annual Report to Shareholders
September 2016BPH Energy Ltd – Corporate Governance Statement
August 2016Preliminary Final Report
August 2016Cortical Dynamics – Semi Finalist in Aust Technologies Contest
June 2016Cortical Patent Update for BAR Monitoring System
June 2016Cortical Dynamics signs letter of intent (LOI) with Device Technologies
May 2016HLS5 Tumour Suppressor Gene Summary
April 2016BPH investee Cortical Dyamics – Patent Update for BAR Monitoring System
April 2016BPH investee Advent Energy update on Seismic Vessel
April 2016BPH Investee Advent Seismic Vessel Contracted
February 2016BPH investee Cortical Dynamics receives CE Mark
January 2016ASX announcement update capital structure Jan 16.pdf
2015
October 2015Annual Report 2015
2014
October 2014Molecular Discovery Systems Ltd – Annual Report 2014
October 2014Cortical Dynamics Limited – Annual Report 2014
September 2014Annual Report 2014
February 2014Patent Update For BacTrak Diagnostic Test
February 2014Appendix 4D -Half year report
2013
October 2013Two New Patents Granted for BAR Monitoring System
October 2013Cortical Dynamics Presents Results of Clinical Trial at Anesthesiology 2013
Sep 2013Annual Report 2013
July 2013Australian Patents Granted for HLS5 Portfolio
May 2013Anaesthetists Survey Highlights Future Trends
May 2013Patent Update for BAR Monitoring System
May 2013Cortical Dynamics Presents Results of Clinical Trial at the Annual Scientific Meeting of the Australian and New Zealand College of Anaesthetists (ANZCA) in Melbourne
April 2013Appendix 4C
February 2013Appendix 4D- Half Year Report
January 2013Cortical Dynamics Ltd Partners with the University of Melbourne in an ARC Linkage Grant
January 2013Japanese Patent Granted For BacTrac Diagnostic Test
January 2013Second Australian Patent Granted For BAR Monitoring System
2012
November 2012Second Chinese Patent Granted For BAR Monitoring System
November 2012Cortical Dynamics Ltd – BAR Monitor Clinical Trial Recruitment Completed
October 2012NOTICE OF ANNUAL GENERAL MEETING
October 2012Appendix 4E
July 2012Molecular Discovery Systems Signs Collaboration Agreement with Peter MacCallum Cancer Centre
June 2012ASX Australian Patent Granted for HLS5 Patent Family
May 2012Cortical Dynamics Ltd – Second US Patent Granted For BAR Monitoring System
April 2012Cortical Dynamics Ltd – Supplementary Prospectus
April 2012US Patent Granted for HLS5 Patent Family
March 2012Cortical Dynamics Ltd – EXTENSION OF INITIAL PUBLIC OFFERING
March 2012Cortical Dynamics Commences Enrolment for Clinical Trials
February 2012Half Year Report
February 2012Cortical Dynamics Awarded WA Innovation Vouchers
January 2012Cortical Dynamics to present at Biotech Showcase 2012
2011
December 2011EXTENSION OF INITIAL PUBLIC OFFERING
December 2011Finalist in the Australian Innovation Challenge
November 2011Ethics Approval Obtained for BAR Monitor Trial in Melbourne
November 20113rd NEW ZEALAND PATENT GRANTED FOR BAR MONITORING SYSTEM
September 2011Cortical Dynamics Initial Public Offer – Closing Date Extended
September 2011Results of study of BAR System at Swinburne University
September 2011NEW ZEALAND PATENT GRANTED FOR BAR MONITORING SYSTEM
August 2011Cortical Dynamics Ltd – Initial Public Offering
July 2011Key HLS5 Cancer Role Report
June 2011Japanese Patent Granted for BAR Monitoring System.pdf
June 2011Cortical Dynamics Ltd- Initial Public Offering.pdf
March 2011BAR MONITORING SYSTEM FEATURED IN THE MAGAZINE OF SWINBURNE UNIVERSITY OF TECHNOLOGY
March 2011Channel Nine Mining Matters Program features an update from Advent Energy BPH
2010
December 2010 Amended Indicative timetable
December 2010New Seaclem 1- Progress Report.pdf
December 2010Capital Raising and Investment Update
December 2010Change of Name to BPH Energy Limited
December 2010Results of 2010 General Meeting
November 2010BPH PROSPECTUS 2010
November 2010Second Independent report finds PEP11 New Seaclem-1 Well Gas “Highly Likely”
November 2010PEP11 Drilling Regulatory Approvals received from NSW Department of Industry and Investment
November 2010Dr Robin Scaife to Present at Melanoma Symposium Today
November 2010Advent Energy Update – Investment and Drilling
October 2010Cortical Dynamics Poster Presentation at Anesthesiology 2010
October 2010Further investment in Advent Energy Ltd
September 2010HLS5 presented at The Society for Hematology and Stem Cells
August 2010BPH Shareholder Update
July 2010BPH to engage in Melanoma Drug Discovery
July 2010Cortical Dynamics Paper Published in Anesthesiology Journal
July 2010Cortical Dynamics Australian Patent Granted
July 2010Advent Energy Announcement Clarification
July 2010Advent Energy Update
June 2010BPH Corporate Update on the HLS5 Tumor Suppressor Gene
June 2010Expiry of Quoted Options – BPHO
May 2010Technical CSIRO Study Update for BPH investee Advent Energy
May 2010Cortical Dynamics Completes Functionality Trial
May 2010BPH Corporate – 2010 BIO International Convention
May 2010Cortical Dynamics ANZCA Poster
April 2010Advent Energy Contracts Drilling Rig for PEP11
April 2010Advent Energy Fudning Update
April 2010Advent Energy PEP11 Site Survey Update
April 2010Advent Energy Investment Update
March 2010Anti-microtubule Cancer Therapeutics Update
March 2010BPH Corporate Presentation
March 2010Advent Energy Update – PEP11 Site Survey
March 2010BPH Corporate Results of 2010 General Meeting
March 2010Cortical Dynamics to present at the Australian and New Zealand College of Anaesthetists (ANZCA) and Faculty of Pain Medicine
February 2010Advent Energy Limited – PEP 11 Operational Update
February 2010Advent Energy Limited – PEP 11 Update
January 2010Results of 2009 Annual General Meeting
January 2010BPH Placement
January 2010BPH Initiates Investment Option
2009
December 2009Cortical Dynamics Successfully Completes NHMRC Grant
December 2009Allocation of Placement
December 2009Results of 2009 General Meeting
December 2009Change of Name to BPH Corporate Limited
December 2009BioPharmica Limited Completes Capital Raising
November 2009BioPharmical Limited Notice of General Meeting – Amended Indicative Timetable
November 2009Extension of Time to Hold 2009 Annual General Meeting
November 2009Hls5 to be presented at the 51st ASH Annual Meeting
November 2009NHMRC $608,500 Grant for HLS5
November 2009Update – BioPharmica Limited 2009 Annual General Meeting
October 2009Molecular Discovery Systems Spin Off and IPO
September 2009Completion of Shareholder Share Purchase Plan
September 2009Extension of Shareholder Share Purchase Plan
September 2009BioPharmica Signs Option Deed with Advent Energy
September 2009Advent Energy Limited Lodges EPBC Act Referrals
September 2009New IPO for BioPharmica
September 2009Advent Investment Opportunity
August 2009Anti-Mitotic Project Update
August 2009BioPharmica Confirms 100% Ownership of New Anti Cancer Agents
August 2009US Patent Granted for HLS5
August 2009Promising Results for Cortical Dynamics
June 2009Cortical Dynamics Project Update
May 2009NZ Patent Granted for Cortical Dynamics
May 2009HLS5 Project Awarded Grant for Melanoma Research
March 2009Molecular Discovery Systems High Content Screening Service
March 2009Novel Cancer Therapeutic Discovery
February 2009Half Yearly Financial Report December 2008
February 2009HLS5 presented at the 21st Lorne Cancer Conference 2009
January 2009Diagnostic Array Systems Complete Grant for the BacTrak System
2008
November 2008BioPharmica Ltd Annual Report 2008
October 2008International Publication Milestone for BAR Monitor
September 2008HLS5 at BIO2008
September 2008HLS5 Presented at ComBio 2008 in Canberra
September 2008New Drug – Cancer Impact
July 2008Genes Identified in a Hemopoietic Lineage Switch Influence Transcription
June 2008HLS5 Screening yields New Drug Leads
May 2008HLS5 Conference Coverage – Leave it to the Master Gene
April 2008Fujikura and BioPharmica Sign Collaboration Agreement
April 2008BioPharmica and GE Healthcare Collaboration Completion
February 2008International HLS5 Scientific Publication
2007
December 2007Encouraging Trial Results for Monitoring Brain Function
October 2007MDSystems Image Analysis Used to Help Publish Technique Article
October 2007Cortical Dynamics Update
August 2007BioPharmica Ltd Notice of Meeting – Indicative Timetable
July 2007ABC TV Coverage on Cortical Dynamics
July 2007Re: Clarification of Shareholder Share Purchase Pland and Proposed Cortical Dynamics Spin-Off
July 2007Re: BioPharmica Limited Shareholder Share Purchase Plan
July 2007Invitation to participate – BioPharmica Share Purchase Plan
June 2007BioPharmica Investee Wins Commercial Grant
June 2007BioPharmica to move to 83.5% in HLS5 investment
June 2007GBA: IPO intention for BioPharmica Ltd
June 2007New IPO intended for BioPharmica
May 2007BAR Monitoring System Features on ABC Catalyst Program
May 2007BioPharmica Limited Joint Venture Patents as at 7 May 2007
May 2007HLS5 Tumour Suppressor Gene – Developments Update
March 2007NHMRC Grant Funding Awarded to BioPharmica Project
March 2007SERS Probe in Commercial Development Agreement
March 2007Cell-Based imaging for tissue samples – Australian Biotechnology News
2006
December 2006Australian Bacterial DNA Test Success
November 2006BioPharmica and GE Healthcare Collaboration Update
October 2006BioPharmica in GE Healthcare Collaboration – Shareholder Letter
October 2006BioPharmica in GE Healthcare Collaboration
September 2006BPH secures “Tumour Suppressor Factor” Patent number 784629
June 2006Australian Technology to Monitor Brain Function in Clinical Trials
May 2006Successful Brain Function Monitor Results
May 2006Uni California Expert to Work with MDS on Image Analysis
April 2006Launch of Molecular Discovery Systems
February 2006Successful Lung Disease Genechip Trial
January 2006Lung Disease Test Results Update
January 2006Bacterial Genechip Trial Completed
January 2006HLS5 Gene implicated in Huntington’s and AIDS
2005
September 2005BAR Monitor Validation Trials
September 2005HLS5 Gene Project Update
May 2005Successful HLS5 Cancer Gene Pre-clinical Trial
March 2005BAR System Passes International EMC Testing
February 2005BioPharmica Cancer Gene Pilot Trial
January 2005Cancer expert joins BioPharmica HLS5 Reserach Team
2004
December 2004New Anaesthesia Monitoring Trial at Royal Melbourne Hospital
December 2004RMIT University Bacterial Research Agreement
November 2004Federal Gov Funds BioPharmica DAS Project
November 2004Scientists Win Grant Recognition
September 2004Swinburne Uni and BioPharmica Biotech Agreement
September 2004Brain Science Company Signs with BioPharmica
September 2004BioPharmica Cancer Gene Progress
September 2004BioPharmica Prototype and Pilot Test